Companies / BOC Sciences / Lexatumumab
BOC Sciences

Lexatumumab | BOC Sciences

Lexatumumab is a human monoclonal agonistic antibody directed against TRAIL-R2. Lexatumumab binds to TRAIL-R2 thus inducing apoptosis of TRAIL-R2-expressing tumor cells.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.